← Leaderboards
Joe Verghese
Albert Einstein College Of Medicine
$39,214,466
Attributed
$51,987,080
Total exposure
20
Grants
19
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.8M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,987,080 · 20
By mechanism
R01$36,661,213 · 9
U01$4,365,934 · 1
P01$3,423,880 · 3
UH3$2,781,797 · 1
R56$2,051,876 · 2
UG3$1,373,936 · 1
Top collaborators
- Pavagada S Mathuranath11 shared
- Roee Holtzer9 shared
- Nir J Barzilai7 shared
- Helena Knotkova5 shared
- Helena M Blumen3 shared
- Malaz Boustani3 shared
- Sofiya Milman3 shared
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Sofiya Milman$8,537,228
- Derek Major Huffman$7,446,355
- Pavagada S Mathuranath$2,489,042
- Steven Suey-Ming Chin$1,944,185
- Aditi Shastri$2,374,931
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposCognitiveAgingElderlyBaseDementiaGaitReportingLinkCommunitiesMotorParticipantImpaired CognitionHigh RiskBiologicalCohortSyndromeComplexCognitionRisk FactorsSamplingCognitive TestingBlood VesselsDisability
Grant awards (87)
Gait as a Preclinical Marker for Alzheimer's Disease and Dementia: insights from super-movers, usual-movers, and slow-movers$863,160
R01 · FY2025 · AG · contact PI
Cognitive decline and dementia in older Kerala Americans$820,874
R01 · FY2025 · AG · contact PI
Multi-omics approach to frailty resilience$689,031
R01 · FY2025 · AG
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$1,467,612
R01 · FY2024 · AG · contact PI
Gait as a Preclinical Marker for Alzheimerâs Disease and Dementia: insights from super-movers, usual-movers, and slow-movers$1,174,367
R01 · FY2024 · AG · contact PI
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial$1,039,233
R01 · FY2024 · AG · contact PI
Cognitive decline and dementia in older Kerala Americans$855,415
R01 · FY2024 · AG · contact PI
Multi-omics approach to frailty resilience$719,587
R01 · FY2024 · AG
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial$157,508
U01 · FY2024 · NS · contact PI
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial$2,074,631
U01 · FY2023 · NS · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$1,491,998
R01 · FY2023 · AG · contact PI
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial$1,350,687
R01 · FY2023 · AG · contact PI
Kerala-Einstein Aging Study$651,174
R01 · FY2023 · AG · contact PI
5-Cog Paradigm to Improve Detection of Cognitive Impairment in Primary Care: Pragmatic Clinical Trial$2,133,795
U01 · FY2022 · NS · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$1,533,982
R01 · FY2022 · AG · contact PI
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial$1,350,687
R01 · FY2022 · AG · contact PI
Kerala-Einstein Aging Study$656,632
R01 · FY2022 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$99,690
R01 · FY2022 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$71,207
R01 · FY2022 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$1,553,810
R01 · FY2021 · AG · contact PI
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial$1,346,991
R01 · FY2021 · AG · contact PI
Multi-omics approach to frailty resilience$846,303
R56 · FY2021 · AG
5-Cog Battery to improve detection of cognitive impairment and dementia$821,713
UH3 · FY2021 · NS · contact PI
Kerala-Einstein Aging Study$648,282
R01 · FY2021 · AG · contact PI
Cognitive sequelae of the biological effects of COVID-19 on the nervous system in a health disparity population$304,212
UH3 · FY2021 · NS · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$224,663
R01 · FY2021 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$1,589,909
R01 · FY2020 · AG · contact PI
Non-Invasive Home Neurostimulation for Mild to Moderate Alzheimer's Disease: Double-Blind, Sham Controlled Randomized Clinical Trial$1,138,419
R01 · FY2020 · AG · contact PI
5-Cog Battery to improve detection of cognitive impairment and dementia$832,343
UH3 · FY2020 · NS · contact PI
Kerala-Einstein Aging Study$664,782
R01 · FY2020 · AG · contact PI
5-Cog Battery to improve detection of cognitive impairment and dementia$823,529
UH3 · FY2019 · NS · contact PI
Kerala-Einstein Aging Study$732,176
R01 · FY2019 · AG · contact PI
Cognitive intervention to improve simple and complex walking$637,929
R01 · FY2019 · AG · contact PI
Cognitive intervention to improve simple and complex walking$293,577
R01 · FY2019 · AG · contact PI
Social Dancing Intervention for older adults at high risk of Alzheimer's disease and other dementias: A pilot study$167,000
R21 · FY2019 · AG · contact PI
Cognitive intervention to improve simple and complex walking$568,677
R01 · FY2018 · AG · contact PI
5-Cog Battery to improve detection of cognitive impairment and dementia$475,476
UG3 · FY2018 · NS · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$438,319
R01 · FY2018 · AG · contact PI
5-Cog Battery to improve detection of cognitive impairment and dementia$336,366
UG3 · FY2018 · NS · contact PI
Social Dancing Intervention for older adults at high risk of Alzheimer's disease and other dementias: A pilot study$239,271
R21 · FY2018 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$210,272
R01 · FY2018 · AG · contact PI
Cognitive intervention to improve simple and complex walking$75,939
R01 · FY2018 · AG · contact PI
Social Dancing Intervention for older adults at high risk of Alzheimer's disease and other dementias: A pilot study$52,979
R21 · FY2018 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$926,706
R56 · FY2017 · AG · contact PI
Cognitive intervention to improve simple and complex walking$664,693
R01 · FY2017 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$657,603
R01 · FY2017 · AG · contact PI
5-Cog Battery to improve detection of cognitive impairment and dementia$562,094
UG3 · FY2017 · NS · contact PI
Biological and neural mechanisms of falls$498,584
R01 · FY2017 · AG · contact PI
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study$278,867
R56 · FY2017 · AG · contact PI
Biological and neural mechanisms of falls$109,022
R01 · FY2017 · AG · contact PI
Cognitive intervention to improve simple and complex walking$843,952
R01 · FY2016 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$666,393
R01 · FY2016 · AG · contact PI
Biological and neural mechanisms of falls$639,519
R01 · FY2016 · AG · contact PI
Cognitive intervention to improve simple and complex walking$171,801
R01 · FY2016 · AG · contact PI
Cognitive intervention to improve simple and complex walking$695,309
R01 · FY2015 · AG · contact PI
Biological and neural mechanisms of falls$570,390
R01 · FY2015 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$423,242
R01 · FY2015 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$231,519
R01 · FY2015 · AG · contact PI
Biological and neural mechanisms of falls$229,520
R01 · FY2015 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$138,250
R01 · FY2015 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$134,054
R01 · FY2015 · AG · contact PI
Cognitive intervention to improve simple and complex walking$1,075
R01 · FY2015 · AG · contact PI
Role of exceptional longevity genotypes in protection against frailty in aging$680,722
R01 · FY2014 · AG · contact PI
Biological and neural mechanisms of falls$660,709
R01 · FY2014 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$338,609
R01 · FY2014 · AG · contact PI
Biological and neural mechanisms of falls$152,261
R01 · FY2014 · AG · contact PI
Biological and neural mechanisms of falls$674,913
R01 · FY2013 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$309,084
R01 · FY2013 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$333,344
R01 · FY2012 · AG · contact PI
Clinical Core$379,037
P01 · FY2011 · AG · contact PI
Kerala-Einstein Study: Healthy lifestyle, vascular disease, and cognitive decline$371,697
R01 · FY2011 · AG · contact PI
Locomotor Function in Cognitive Aging and Cognitive Decline$165,938
P01 · FY2011 · AG · contact PI
Latent Mobility Abnormalities And Frailty$319,334
R01 · FY2009 · AG · contact PI
Kerala-Einstein study: Risk factors for cognitive decline$104,125
R21 · FY2009 · AG · contact PI
CORE--CLINICAL CORE$635,060
P01 · FY2008 · AG · contact PI
Latent Mobility Abnormalities And Frailty$319,896
R01 · FY2008 · AG · contact PI
Kerala-Einstein study: Risk factors for cognitive decline$141,069
R21 · FY2008 · AG · contact PI
CORE--CLINICAL CORE$626,474
P01 · FY2007 · AG · contact PI
Latent Mobility Abnormalities And Frailty$326,425
R01 · FY2007 · AG · contact PI
CORE--CLINICAL CORE$548,759
P01 · FY2006 · AG · contact PI
Latent Mobility Abnormalities And Frailty$273,524
R01 · FY2006 · AG · contact PI
Latent Mobility Abnormalities and Disability$208,000
K23 · FY2006 · AG · contact PI
CORE--CLINICAL CORE$543,362
P01 · FY2005 · AG
Latent Mobility Abnormalities And Frailty$266,688
R01 · FY2005 · AG
Latent Mobility Abnormalities and Disability$208,000
K23 · FY2005 · AG
CORE--CLINICAL CORE$525,250
P01 · FY2004 · AG
Latent Mobility Abnormalities and Disability$208,000
K23 · FY2004 · AG